18 BMD 430 lecture 18
1. The key difference between active and passive
immunization is:
A. Active immunization provides immediate
immunity
B. Passive immunization requires antigen exposure
C. Active immunization induces memory cell formation
D. Passive
immunization lasts longer than active
C. Active immunization induces memory cell formation
2. Which of the following is an example of
natural passive immunity?
A. Breast milk
antibodies
B. Receiving a flu vaccine
C. Recovering from
measles infection
D. Injection with antivenom
A. Breast milk antibodies
3. Passive immunization is advantageous
because:
A. It provides long-term protection
B. It gives
immediate protection
C. It enhances T cell memory
D. It
can be administered orally only
B. It gives immediate protection
4. The term “horse α-snake” in vaccines refers
to:
A. Recombinant vaccines
B. Source species of
antibodies
C. Attenuated virus strain
D. Chemical adjuvant
B. Source species of antibodies
5. What is the main goal of vaccination?
A. To
treat infections
B. To boost innate immunity
C. To
generate long-term adaptive immune memory
D. To increase white
blood cell count
C. To generate long-term adaptive immune memory
6. The difference between vaccination and
immunization is:
A. Immunization always requires an
injection
B. Vaccination causes passive immunity
C.
Vaccination introduces antigen; immunization is the resulting
protection
D. There is no difference
C. Vaccination introduces antigen; immunization is the resulting protection
7. Which disease is the only one eradicated by
vaccination?
A. Measles
B. Smallpox
C. Polio
D. Tetanus
B. Smallpox
8. Live attenuated vaccines:
A. Contain dead
microorganisms
B. Provide weaker immune responses
C. Can
replicate in the host
D. Cannot cause infection in
immunocompromised people
C. Can replicate in the host
9. Which vaccine type carries no risk of
infection?
A. Live attenuated
B. Inactivated/killed
C. Recombinant vector
D. mRNA
B. Inactivated/killed
10. The oral and inactivated polio vaccines differ
because:
A. Both are live
B. The oral form induces mucosal
IgA immunity
C. The inactivated form is more natural
D.
The oral form is injected
B. The oral form induces mucosal IgA immunity
11. What is an adjuvant?
A. A stabilizer in
vaccines
B. A molecule that enhances immune response
C. A
viral antigen
D. A carbohydrate subunit
B. A molecule that enhances immune response
12. Liposomes and ISCOMs are used in vaccines
to:
A. Kill bacteria directly
B. Deliver antigens more
effectively
C. Replace adjuvants
D. Increase shelf life
B. Deliver antigens more effectively
13. The NVICP (National Vaccine Injury Compensation
Program) was created to:
A. Fund new vaccine research
B.
Compensate people injured by vaccines
C. Mandate vaccinations
for all citizens
D. Approve vaccine licensing
B. Compensate people injured by vaccines
14. The VAERS system is used to:
A. Record and
monitor vaccine side effects
B. Create new vaccines
C.
Approve vaccine safety
D. Distribute vaccines
A. Record and monitor vaccine side effects
15. Non-vaccination can lead to:
A. Herd
immunity
B. Disease outbreaks
C. Higher antibody
levels
D. Reduced transmission
B. Disease outbreaks
16. Therapeutic vaccines are designed to:
A.
Prevent infection
B. Treat existing diseases like cancer or
HIV
C. Induce allergies
D. Replace antibodies
B. Treat existing diseases like cancer or HIV
17. The spike (S) protein of SARS-CoV-2 binds to
which receptor?
A. CD4
B. ACE2
C. MHC I
D. FcγR
B. ACE2
18. The relationship between infectivity and
mortality generally shows:
A. Highly infectious diseases are
always deadly
B. As infectivity increases, mortality often
decreases
C. There is no relationship
D. High mortality
always means high infectivity
B. As infectivity increases, mortality often decreases
19. How do mRNA vaccines work?
A. They deliver
antibodies directly
B. They provide live viruses
C. They
use host cells to make viral proteins that trigger immunity
D.
They neutralize toxins
C. They use host cells to make viral proteins that trigger immunity
20. Herd immunity occurs when:
A. Everyone is
infected
B. Enough people are immune that disease spread is
limited
C. Immunity only exists in animals
D. Only
children are vaccinated
B. Enough people are immune that disease spread is limited
21. What is the main advantage and disadvantage of passive immunization?
A. Advantage: long-lasting; Disadvantage: slow onset
B.
Advantage: immediate protection; Disadvantage: no memory,
short-lived
C. Advantage: stimulates memory; Disadvantage:
requires multiple doses
D. Advantage: prevents viral entry;
Disadvantage: causes autoimmunity
B. Advantage: immediate protection; Disadvantage: no memory, short-lived
22. Which factor contributed MOST to the eradication of smallpox?
A. Animal reservoirs that diluted the virus
B. Lack of
symptoms in infected individuals
C. Human-only reservoir,
visible rash, and an effective vaccine
D. Short survival of the
virus outside the body
C. Human-only reservoir, visible rash, and an effective vaccine
23. What are the three main goals of vaccination?
A. Increase antibody decay, reduce immunity, create tolerance
B. Prevent disease, reduce transmission, achieve herd immunity
C. Boost inflammation, increase fever, activate macrophages
D.
Eliminate all pathogens worldwide
B. Prevent disease, reduce transmission, achieve herd immunity
24. Which option correctly defines an adjuvant and gives an example?
A. A toxin that weakens vaccines; example: botulinum toxin
B.
A compound that enhances immune responses; example: alum
C. A
viral vector for vaccines; example: adenovirus
D. A memory cell
marker; example: CD40L
B. A compound that enhances immune responses; example: alum
25. What is the difference between variolation and vaccination?
A. Variolation uses cowpox; vaccination uses smallpox
B.
Variolation uses weakened virus; vaccination uses inactivated
virus
C. Variolation used smallpox material; vaccination used
cowpox for safer immunity
D. They are identical practices
C. Variolation used smallpox material; vaccination used cowpox for safer immunity
26. What is rational vaccine design?
A. Randomly testing antigens until immunity is generated
B.
Using computational models only
C. Designing vaccines based on
antigen structure, immune mechanisms, and genetics
D. Creating
vaccines without considering immune response
C. Designing vaccines based on antigen structure, immune mechanisms, and genetics
27. How does SARS-CoV-2 enter host cells?
A. Using MHC I receptors
B. Spike protein binding to ACE2
receptors
C. Attaching to red blood cells
D. Binding
complement proteins
B. Spike protein binding to ACE2 receptors
28. What is the purpose of a vaccine booster?
A. To suppress memory cells
B. To reduce antibody
levels
C. To increase or renew memory responses and raise
antibody titers
D. To replace previous vaccinations entirely
C. To increase or renew memory responses and raise antibody titers
29. What is herd immunity threshold?
A. The number of people who choose not to get vaccinated
B.
The percent of a population that must be immune to stop disease
spread
C. The minimum number of vaccine doses needed per
person
D. The amount of viral load required for infection
B. The percent of a population that must be immune to stop disease spread
30. What is the purpose of VAERS?
A. To approve new vaccines
B. To track and investigate reports
of adverse vaccine events
C. To produce vaccines for public
use
D. To measure antibody titers after vaccination
B. To track and investigate reports of adverse vaccine events